Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity. uri icon

authors

  • Mayra Tisminetzky MD PhD
  • Gurwitz, Jerry H
  • Tabada, Grace
  • Reynolds, Kristi
  • Fortmann, Stephen P
  • Garcia, Elisha
  • Pham, Thu
  • Goldberg, Robert
  • Go, Alan S

publication date

  • January 1, 2022